You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HER2 genetic alterations

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non Small Cell Lung Cancer, ERBB2 Mutation-Related Tumors, RC48 Trial in Guanzhou (RC48+Tislelizumab+carboplatin,

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • Guanzhou, China
    SunYat-senU
May 5, 2023

Breast Cancer Trial in Tianjin (Pemigatinib Pill)

Recruiting
  • Breast Cancer
  • Pemigatinib Pill
  • Tianjin, Tianjin, China
    Breast Oncology, Tianjin Medical University Cancer Institute and
Sep 26, 2022

Resistance/Sensitivity and/or Toxicity in Adjuvant Setting for

Recruiting
  • HER2-positive Breast Cancer
  • Blood sample for genetic analysis
  • Strasbourg, France
    Institut de cancérologie Strasbourg Europe
Aug 2, 2022

Malignant Solid Tumors Trial (Sirolimus for Injection (Albumin-bound))

Not yet recruiting
  • Malignant Solid Tumors
  • Sirolimus for Injection (Albumin-bound)
  • (no location specified)
Aug 19, 2022

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma Trial in

Not yet recruiting
  • Anatomic Stage II Breast Cancer AJCC v8
  • +3 more
  • Biospecimen Collection
  • +7 more
  • Portland, Oregon
    SWOG
Sep 27, 2023

Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in New Haven (procedure, drug, biological)

Recruiting
  • Metastatic Malignant Solid Neoplasm
  • Unresectable Malignant Solid Neoplasm
  • Biopsy
  • +2 more
  • Boston, Massachusetts
  • +2 more
Jan 25, 2023

Blood and Tumor Samples From Advanced or Metastatic Estrogen

Active, not recruiting
  • Advanced Breast Carcinoma
  • +8 more
  • Biopsy
  • +2 more
  • Scottsdale, Arizona
  • +2 more
Jan 3, 2023

Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Afatinib

Active, not recruiting
  • Advanced Lymphoma
  • +5 more
  • Afatinib Dimaleate
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
Jun 28, 2022

BARD1 Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Houston, Seattle (Educational Intervention, Genetic

Recruiting
  • BARD1 Gene Mutation
  • +14 more
  • Educational Intervention
  • +3 more
  • Houston, Texas
  • +1 more
Jun 14, 2022

Solid Tumor, Haematological Malignancy, Colorectal Tumors Trial in United Kingdom (Trastuzumab, Pertuzumab)

Recruiting
  • Solid Tumor
  • +10 more
  • Belfast, United Kingdom
  • +25 more
Mar 28, 2023

Solid Tumor Trial in Italy, United States (Derazantinib low dose range, Derazantinib middle dose range, Derazantinib high dose

Completed
Has Results
  • Solid Tumor
  • Derazantinib low dose range
  • +3 more
  • Scottsdale, Arizona
  • +11 more
Mar 7, 2022

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

Active, not recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +22 more
  • Biopsy
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 25, 2022

Tumor, Breast, Congenital, Familial and Genetic Disorders Trial in Netherlands (Alpelisib 150 MG Oral Tablet [Piqray],

Recruiting
  • Neoplasm, Breast
  • Congenital, Familial and Genetic Disorders
  • Almelo, Netherlands
  • +15 more
Jan 11, 2023

Advanced Malignant Solid Tumor, Cholangiocarcinoma, Metastatic Malignant Solid Tumor Trial in Columbus (Infigratinib)

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Feb 15, 2022

Uterine Tumors, Uterine Cervical Tumors, Biliary Tract Tumors Trial in Worldwide (tucatinib, trastuzumab, fulvestrant)

Recruiting
  • Uterine Neoplasms
  • +5 more
  • Goodyear, Arizona
  • +63 more
Aug 15, 2022

HER2 Mutant NSCLC, HER2-positive Metastatic Breast Cancer, HER2 Gene Mutation Trial (ELVN-002, Fam-Trastuzumab Deruxtecan-Nxki,

Not yet recruiting
  • HER2 Mutant Non-small Cell Lung Cancer
  • +3 more
  • (no location specified)
Dec 6, 2022

Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

Recruiting
  • Locally Advanced Bladder Urothelial Carcinoma
  • +18 more
  • Los Angeles, California
  • +2 more
Jun 28, 2022

Advanced Solid Tumor, Head and Neck Squamous Cell Carcinoma, Bladder Carcinoma Trial in Duarte, Iowa City, New York

Recruiting
  • Advanced Solid Tumor
  • +13 more
  • Duarte, California
  • +3 more
Oct 25, 2022

Breast Cancer Trial in Marseille (M1774, Fulvestrant injection)

Not yet recruiting
  • Breast Cancer
  • Marseille, France
    Institut Paoli Calmettes
Aug 9, 2023

Gastric Adenocarcinoma Trial in Worldwide (Derazantinib, Derazantinib-paclitaxel-ramucirumab, Derazantinib-atezolizumab)

Completed
  • Gastric Adenocarcinoma
  • Orlando, Florida
  • +80 more
Jan 13, 2023

Atypical Hemolytic Uremic Syndrome, Membranoproliferative Glomerulonephritis, Autosomal Dominant Polycystic Kidney Trial in

Not yet recruiting
  • Atypical Hemolytic Uremic Syndrome
  • +3 more
  • Skin biopsy
  • Ranica, BG, Italy
    Centro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Da
Aug 9, 2023

NSCLC Trial in Canton, Houston (FWD1509 MsOH)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • FWD1509 MsOH
  • Canton, Ohio
  • +1 more
Jul 20, 2022

Urothelial Carcinoma, Bladder Cancer, Urethral Cancer Trial in United States (Biospecimen Collection)

Active, not recruiting
  • Urothelial Carcinoma
  • +3 more
  • Biospecimen Collection
  • Los Angeles, California
  • +7 more
Feb 14, 2022

Tumors Trial in France (Blood and tumor samples)

Recruiting
  • Neoplasms
  • Blood and tumor samples
  • Annecy, France
  • +5 more
Apr 8, 2022

HER2-Positive Cancer Trial in Wuhan

Active, not recruiting
  • HER2-Positive Cancer
    • Wuhan, Hubei, China
      TongjiHospital
    Sep 7, 2022